Gargoyle Investment Advisor’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-24,679
Closed -$2.33M 105
2018
Q3
$2.33M Sell
24,679
-4,466
-15% -$424K 1.68% 18
2018
Q2
$2.7M Hold
29,145
1.5% 12
2018
Q1
$2.76M Buy
29,145
+19,242
+194% +$2.11M 1.13% 22
2017
Q4
$958K Sell
9,903
-2,022
-17% -$191K 0.38% 78
2017
Q3
$1.06M Sell
11,925
-1,392
-10% -$106K 0.39% 81
2017
Q2
$965K Hold
13,317
0.38% 82
2017
Q1
$868K Buy
13,317
+4,813
+57% +$303K 0.34% 93
2016
Q4
$533K Buy
+8,504
New +$519K 0.21% 125

Other funds holding ABBV

Gargoyle Investment Advisor's ABBV Position: Q4 2018 in Review

Gargoyle Investment Advisor sold out of AbbVie (ABBV) in Q4 2018, closing a stake of 24,679 shares — an estimated $2.33M sold.

Gargoyle Investment Advisor first reported a position in ABBV in Q4 2016 and held it in 8 quarters. The position peaked at $2.76M in Q1 2018. 2,062 funds tracked by Wall St. Rank hold ABBV as of Q4 2018.

  • Gargoyle Investment Advisor reported no remaining AbbVie position as of Q4 2018 after selling out during the quarter.
  • Gargoyle Investment Advisor sold 24,679 AbbVie shares in Q4 2018, an estimated $2.33M.
  • Gargoyle Investment Advisor first reported a position in AbbVie in Q4 2016 and held it in 8 quarters.
  • Gargoyle Investment Advisor's AbbVie position peaked at $2.76M in Q1 2018.
  • 2,062 funds tracked by Wall St. Rank held AbbVie as of Q4 2018.

Based on Gargoyle Investment Advisor's 13F filing for Q4 2018, filed 14 Feb 2019.